Bubendorf, Switzerland, Thursday, December 21, 2017 – CIS Pharma’s bio-membrane project has reached the first milestone. The polymer chemistry experts developed the a first prototype compatible with the 3D printing process. As key project milestones are achieved, the Swiss Nanoscience Institute will grant CIS Pharma a prolonged funding of its bio-membrane project: the cooperation with the University of Applied Sciences, FHNW in Muttenz and the University of Basel has a prestigious outlook and is expected to reach the proof of concept during the project.

About Swiss Nanoscience Institute

The Swiss Nanoscience Institute, SNI, is a center of excellence for nanosciences and nanotechnology. It was founded in 2006 by the University of Basel and the Canton Aargau in order to support research, education, and technology transfer in nanosciences and in nanotechnology. The SNI emerged from the National Center of Competence in Research, NCCR, Nanoscale Science, which was founded in 2001. In the SNI network, interdisciplinary teams of scientists of different research institutions in Northwestern Switzerland conduct basic and applied research and actively support knowledge and technology transfer to the industry. Within the study of nanoscience and the PhD School, the SNI trains young scientists and prepares them for careers in industry and academia. The SNI provides services to partners from research and industry, is involved in public relations and specifically supports various initiatives, particularly those aiming at interested young people and their teachers in natural sciences.

About CIS Pharma AG

CIS Pharma AG is an innovator in the life science industry. The company was founded in 1952 and is family owned. In our laboratories, we synthesize novel molecules, develop new biomaterials and create cutting-edge medical devices. Our mission is to improve the risk-benefit profile of therapeutics that are the standard of care, thereby improving patient’s experience and treatment outcome. Medical need, patient centricity and digital technology are key to our research and development programs. CIS Pharma is located in the region of Basel, Switzerland, one of the most successful life sciences locations in the world. For more information about the company, visit our website www.cis-pharma.com.